Injury Site Specific Xenon Delivered by Platelet Membrane‐Mimicking Hybrid Microbubbles to Protect Against Acute Kidney Injury via Inhibition of Cellular Senescence

Abstract

AbstractInhalation of xenon gas improves acute kidney injury (AKI). However, xenon can only be delivered through inhalation, which causes non‐specific distribution and low bioavailability of xenon, thus limiting its clinical application. In this study, xenon is loaded into platelet membrane‐mimicking hybrid microbubbles (Xe‐Pla‐MBs). In ischemia‐reperfusion‐induced AKI, intravenously injected Xe‐Pla‐MBs adhere to the endothelial injury site in the kidney. Xe‐Pla‐MBs are then disrupted by ultrasound, and xenon is released to the injured site. This release of xenon reduced ischemia‐reperfusion‐induced renal fibrosis and improved renal function, which are associated with decreased protein expression of cellular senescence markers p53 and p16, as well as reduced beta‐galactosidase in renal tubular epithelial cells. Together, platelet membrane‐mimicking hybrid microbubble‐delivered xenon to the injred site protects against ischemia‐reperfusion‐induced AKI, which likely reduces renal senescence. Thus, the delivery of xenon by platelet membrane‐mimicking hybrid microbubbles is a potential therapeutic approach for AKI.